Seneca Foods Corporation
SENEBSeneca Foods Corporation's earnings have outrun its stock. EPS grew +181.2% in a year against a +79.3% price move.
The sharpest disagreement: annual EPS moved +181.2% against a +79.3% price move — the market has not yet caught up with the delivery.
The price is between stages while the P/E sits at the 40th percentile of its own 1-year range. Underneath, the last four quarters read improving, and 229% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Seneca Foods Corporation trades at $187, between stages. It sits at 80% of a 52-week range of $102 to $209. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is between stages. At $187 it trades near its long-run average and sits at 80% of its 52-week range ($102–$209).
Against the market, two honest reads. Cumulative: over the last 1.2 years the stock moved +85% while the S&P 500 moved +24% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Seneca Foods Corporation trades at 10.4× P/E, mid-range by its own standards (40th percentile). Its long-run median P/E is 11.1×, measured across 1.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 10.4× is mid-range by its own standards (40th percentile), against a long-run median of 11.1× measured over 1.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +181.2% against a +79.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Seneca Foods Corporation reads as improving on its fundamental arc. Improving — profit growth bottomed 3 quarters ago at −40.0% and has held its recovery at +266.7%, ROCE holding at 8.7%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +5.1% | +3.2% | — | — |
| Profit | +175.0% | +122.4% | — | — |
| EPS | +181.2% | +142.7% | — | — |
| Stock price | +79.3% | — | — | — |
4-Factor Sector Score
59.4/100 — rank 26 of 30 in Packaged Foods · 46% evidence confidence · provisional, ranked below fully-evidenced peers
Seneca Foods Corporation scores 59.4 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 26. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 22.8 + 10.9 + 15.7 + 10 = 59.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Seneca Foods Corporation reported $0.4 B of revenue in the Mar 26 quarter, +11.4% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 4.5% a year. The last full year, FY26, came in at $1.7 B. The last four reported quarters add to $1.7 B.
FY26 revenue came in at $1.7 B (+5.1% on the year), capping 4 years at 4.5% compound. The latest quarter (Mar 26) printed $0.4 B, +11.4% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +5.1% growth against the decade's 4.5% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +5.1% over the last 4 quarters against +6.6%/yr over the last 8 — stabilising; TTM profit +266.7% vs +35.4%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Seneca Foods Corporation's operating margin is 5.1% in the Mar 26 quarter, +5.1 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 1.3% to 9.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 5.1%, +5.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.3%–9.0%, and FY26's 9.0% is the top of that band — a record year.
Why the margin moved: operating margin went +5.1 pp year on year while gross margin went +4.6 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Seneca Foods Corporation earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY26 profit was $0.1 B. The 4-year compound rate is 21.8%. That is 7.7% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Mar 26 profit was $0.0 B, null year on year. On the full year, FY26 printed $0.1 B (+175.0%), and the 4-year compound rate is 21.8%.
Pace comparison, last four quarters: profit +166.7% vs revenue +5.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 229% of Seneca Foods Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $0.2 B of operating cash against $0.1 B of profit. After $0.0 B of capital spending, $0.2 B was left as free cash.
FY26: operating cash of $0.2 B against reported profit of $0.1 B, leaving free cash of $0.2 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 229% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Seneca Foods Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Seneca Foods Corporation earns a ROE of 15% in FY26. That is up from a trough of 2% in FY23. Return on invested capital clears the cost of that capital by +8.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 6.6% net margin on 1.33× asset turns.
FY26 ROE is 15%, recovered from a FY23 trough of 2% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 6.6% net margin × 1.33× asset turns × 1.64× balance-sheet leverage ≈ 14.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 12.8% − 4.4% = a +8.4 pp spread. The 4.4% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend
Seneca Foods Corporation pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Seneca Foods Corporation does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Seneca Foods Corporation carries total debt of $0.3 B against shareholder equity of $0.8 B as of Mar 26, a debt-to-equity of 0.39. On the annual view that ratio went from 0.31 in FY22 to 0.39 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $0.3 B against shareholder equity of $0.8 B — a debt-to-equity of 0.39. On the annual view, debt-to-equity went from 0.31 (FY22) to 0.39 (FY26). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
0.0% of Seneca Foods Corporation's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 7.7 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 0.0% of the float is sold short, and at typical trading volumes it would take about 7.7 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Seneca Foods Corporation: the Z-score reads 4.38. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 4.38 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 4.38.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Darling Ingredients Inc.DAR | 68.3/100Thin evidence · provisional56% evidence | BREAKING OUT | 23.1/35 Revenue — · PAT — · OPM change 9.5 pp 39% evidence | 17.1/25 ROCE 12% · OPM 14.6% 76% evidence | 9.8/20 P/E 15.2× · PEG — 15% evidence | 18.3/20 RS sector 27.3% · RS bench 10.7% · 1Y 90.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 17.1 + 9.8 + 18.3 = 68.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2The J. M. Smucker CompanySJM | 62.3/100Mixed-positive evidence64% evidence | ASLEEP | 22.5/35 Revenue 3.7% · PAT — · OPM change 47.5 pp 62% evidence | 12.9/25 ROCE 3.1% · OPM 19.6% 76% evidence | 9.1/20 P/E 23× · PEG — 15% evidence | 17.8/20 RS sector 19.8% · RS bench 3.1% · 1Y 10.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 12.9 + 9.1 + 17.8 = 62.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Central Garden & Pet CompanyCENT | 60.4/100Mixed-positive evidence66% evidence | FADING | 19.5/35 Revenue 0.2% · PAT 37.9% · OPM change 0.8 pp 53% evidence | 13.7/25 ROCE 8.8% · OPM 12.6% 57% evidence | 15.1/20 P/E 12.1× · PEG 0.25 65% evidence | 12.1/20 RS sector 12.6% · RS bench -2.8% · 1Y 18.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 13.7 + 15.1 + 12.1 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4The Campbell's CompanyCPB | 52.7/100Mixed-positive evidence81% evidence | ASLEEP | 21.7/35 Revenue -2.9% · PAT 33.9% · OPM change 3.6 pp 83% evidence | 11.9/25 ROCE 2% · OPM 10.1% 76% evidence | 15.2/20 P/E 10.3× · PEG 0.3 65% evidence | 3.9/20 RS sector -16.7% · RS bench -29% · 1Y -39.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 11.9 + 15.2 + 3.9 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5John B. Sanfilippo & Son, Inc.JBSS | 52.0/100Thin evidence · provisional60% evidence | ASLEEP | 16.6/35 Revenue 5.1% · PAT 21.4% · OPM change -2.4 pp 53% evidence | 13.9/25 ROCE 5.2% · OPM 8.4% 57% evidence | 13.9/20 P/E 13.6× · PEG 0.67 65% evidence | 7.6/20 RS sector -5% · RS bench -18.3% · 1Y 6.2%1 of 12 weeks ahead 70% evidence |
| Exact sum: 16.6 + 13.9 + 13.9 + 7.6 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Ingredion IncorporatedINGR | 50.8/100Mixed-positive evidence66% evidence | ASLEEP | 14.3/35 Revenue -2.2% · PAT 7.2% · OPM change -3.9 pp 53% evidence | 14.1/25 ROCE 3.1% · OPM 11.3% 57% evidence | 12.5/20 P/E 10.9× · PEG 1.14 65% evidence | 9.9/20 RS sector -5% · RS bench -18.7% · 1Y -20.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.3 + 14.1 + 12.5 + 9.9 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Utz Brands, Inc.UTZ | 50.4/100Thin evidence · provisional56% evidence | BREAKING OUT | 14.4/35 Revenue 2.3% · PAT -144.1% · OPM change 0.6 pp 53% evidence | 7.5/25 ROCE 0.3% · OPM 2.2% 57% evidence | 8.5/20 P/E 1046× · PEG — 15% evidence | 20.0/20 RS sector 51.5% · RS bench 30.1% · 1Y 17.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 7.5 + 8.5 + 20 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8The Kraft Heinz CompanyKHC | 49.5/100Mixed-negative evidence64% evidence | ASLEEP | 19.6/35 Revenue -1.6% · PAT — · OPM change 22.8 pp 62% evidence | 5.0/25 ROCE -9.4% · OPM -102.7% 76% evidence | 9.9/20 P/E 13.8× · PEG — 15% evidence | 15.0/20 RS sector 4.2% · RS bench -10.5% · 1Y -9.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 5 + 9.9 + 15 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Mama's Creations, Inc.MAMA | 47.7/100Mixed-negative evidence81% evidence | FADING | 24.1/35 Revenue 46.5% · PAT 50% · OPM change 0.5 pp 83% evidence | 11.4/25 ROCE 5.3% · OPM 5% 76% evidence | 5.6/20 P/E 94.6× · PEG 2.6 65% evidence | 6.6/20 RS sector -2.2% · RS bench -15.7% · 1Y 25.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.1 + 11.4 + 5.6 + 6.6 = 47.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -2.2% and the one-year return is 25.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Smithfield Foods, Inc.SFD | 46.9/100Mixed-negative evidence66% evidence | ASLEEP | 17.3/35 Revenue 7.5% · PAT 12.1% · OPM change 0.3 pp 53% evidence | 13.4/25 ROCE 3.1% · OPM 8.8% 57% evidence | 13.5/20 P/E 10.4× · PEG 0.96 65% evidence | 2.7/20 RS sector -15.5% · RS bench -27.3% · 1Y -18.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 13.4 + 13.5 + 2.7 = 46.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11JBS N.V.JBS | 46.8/100Mixed-negative evidence66% evidence | ASLEEP | 15.4/35 Revenue 12.1% · PAT -11.3% · OPM change -2.3 pp 53% evidence | 9.8/25 ROCE 1.5% · OPM 2.2% 57% evidence | 15.5/20 P/E 11.3× · PEG 0.16 65% evidence | 6.1/20 RS sector -12.8% · RS bench -25.4% · 1Y -20.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 9.8 + 15.5 + 6.1 = 46.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Nomad Foods LimitedNOMD | 46.4/100Thin evidence · provisional60% evidence | ASLEEP | 13.2/35 Revenue -2.9% · PAT -40.9% · OPM change -1.8 pp 53% evidence | 10.6/25 ROCE 1.1% · OPM 7.9% 57% evidence | 11.5/20 P/E 9.3× · PEG 1.49 65% evidence | 11.1/20 RS sector 0.7% · RS bench -13.8% · 1Y -18.4%9 of 12 weeks ahead 70% evidence |
| Exact sum: 13.2 + 10.6 + 11.5 + 11.1 = 46.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Freshpet, Inc.FRPT | 45.8/100Mixed-negative evidence61% evidence | FADING | 20.4/35 Revenue 12.1% · PAT 100% · OPM change 5.9 pp 40% evidence | 7.2/25 ROCE 0.3% · OPM 1.5% 57% evidence | 5.3/20 P/E 15.8× · PEG 2.98 65% evidence | 12.9/20 RS sector 0.7% · RS bench -13.8% · 1Y 16.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 7.2 + 5.3 + 12.9 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14McCormick & Company, IncorporatedMKC-V | 45.6/100Mixed-negative evidence75% evidence | ASLEEP | 18.1/35 Revenue 9.5% · PAT 1.1% · OPM change -0.5 pp 83% evidence | 14.3/25 ROCE 2.4% · OPM 14.3% 76% evidence | 6.7/20 P/E 7.9× · PEG 4.94 65% evidence | 6.5/20 RS sector -9.6% · RS bench -23% · 1Y -25.1%4 of 12 weeks ahead 70% evidence |
| Exact sum: 18.1 + 14.3 + 6.7 + 6.5 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15BellRing Brands, Inc.BRBR | 45.2/100Thin evidence · provisional60% evidence | ASLEEP | 12.8/35 Revenue 6.4% · PAT -43.6% · OPM change -5.2 pp 53% evidence | 15.6/25 ROCE 9.2% · OPM 11% 57% evidence | 13.8/20 P/E 12.5× · PEG 0.7 65% evidence | 3.0/20 RS sector -54.6% · RS bench -62% · 1Y -78.5%5 of 12 weeks ahead 70% evidence |
| Exact sum: 12.8 + 15.6 + 13.8 + 3 = 45.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Lamb Weston Holdings, Inc.LW | 45.2/100Thin evidence · provisional56% evidence | ASLEEP | 14.9/35 Revenue — · PAT — · OPM change -8.3 pp 39% evidence | 12.1/25 ROCE 2.8% · OPM 8.1% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 8.7/20 RS sector -5% · RS bench -18.7% · 1Y -21.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 12.1 + 9.5 + 8.7 = 45.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Conagra Brands, Inc.CAG | 43.6/100Thin evidence · provisional56% evidence | ASLEEP | 15.4/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence | 6.9/25 ROCE -10.8% · OPM 10% 76% evidence | 10.6/20 P/E 11.2× · PEG — 15% evidence | 10.7/20 RS sector -4.9% · RS bench -19% · 1Y -21.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 6.9 + 10.6 + 10.7 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18The Marzetti CompanyMZTI | 41.7/100Mixed-negative evidence66% evidence | ASLEEP | 15.6/35 Revenue 2.8% · PAT 3.5% · OPM change -0.6 pp 53% evidence | 13.4/25 ROCE 4.1% · OPM 10.3% 57% evidence | 8.7/20 P/E 21.6× · PEG 1.71 65% evidence | 4.0/20 RS sector -22.7% · RS bench -34.4% · 1Y -41.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 13.4 + 8.7 + 4 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Pilgrim's Pride CorporationPPC | 40.0/100Thin evidence · provisional56% evidence | ASLEEP | 12.8/35 Revenue — · PAT — · OPM change -5.5 pp 39% evidence | 9.0/25 ROCE 0.9% · OPM 3.6% 76% evidence | 10.2/20 P/E 12.5× · PEG — 15% evidence | 8.0/20 RS sector -14.4% · RS bench -27.2% · 1Y -31.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 9 + 10.2 + 8 = 40 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Flowers Foods, Inc.FLO | 38.0/100Thin evidence · provisional56% evidence | ASLEEP | 16.8/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence | 10.2/25 ROCE 2.3% · OPM 5.1% 76% evidence | 9.4/20 P/E 21.5× · PEG — 15% evidence | 1.6/20 RS sector -33.5% · RS bench -43.5% · 1Y -55%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 10.2 + 9.4 + 1.6 = 38 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Post Holdings, Inc.POST | 37.9/100Mixed-negative evidence66% evidence | ASLEEP | 18.2/35 Revenue 7.2% · PAT -5% · OPM change 1.1 pp 53% evidence | 11.7/25 ROCE 1.8% · OPM 10.4% 57% evidence | 5.6/20 P/E 16.6× · PEG 2.92 65% evidence | 2.4/20 RS sector -19.3% · RS bench -31% · 1Y -30.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.2 + 11.7 + 5.6 + 2.4 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22J&J Snack Foods Corp.JJSF | 37.4/100Thin evidence · provisional60% evidence | ASLEEP | 14.5/35 Revenue -2.1% · PAT -23.7% · OPM change -1.2 pp 53% evidence | 9.3/25 ROCE 0.2% · OPM 0.5% 57% evidence | 3.8/20 P/E 26.8× · PEG 6.43 65% evidence | 9.8/20 RS sector -1.8% · RS bench -16% · 1Y -18.9%5 of 12 weeks ahead 70% evidence |
| Exact sum: 14.5 + 9.3 + 3.8 + 9.8 = 37.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Hormel Foods CorporationHRL | 36.9/100Mixed-negative evidence71% evidence | ASLEEP | 12.9/35 Revenue 2.5% · PAT -37.6% · OPM change -1.3 pp 83% evidence | 10.8/25 ROCE 1.8% · OPM 7.3% 76% evidence | 8.9/20 P/E 25.4× · PEG — 15% evidence | 4.3/20 RS sector -9.5% · RS bench -22.4% · 1Y -20.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 10.8 + 8.9 + 4.3 = 36.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24General Mills, Inc.GIS | 30.4/100Adverse evidence71% evidence | ASLEEP | 5.6/35 Revenue -5.4% · PAT -103.7% · OPM change -56.5 pp 83% evidence | 6.8/25 ROCE -8.6% · OPM -45.4% 76% evidence | 10.7/20 P/E 10.9× · PEG — 15% evidence | 7.3/20 RS sector -11.8% · RS bench -24.9% · 1Y -32.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 5.6 + 6.8 + 10.7 + 7.3 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25The Simply Good Foods CompanySMPL | 24.0/100Adverse evidence65% evidence | ASLEEP | 5.1/35 Revenue -4.5% · PAT -237.2% · OPM change -29.6 pp 83% evidence | 6.0/25 ROCE -2.3% · OPM -14% 76% evidence | 9.2/20 P/E 21.9× · PEG — 15% evidence | 3.7/20 RS sector -33.2% · RS bench -43.5% · 1Y -61.1%1 of 12 weeks ahead 70% evidence |
| Exact sum: 5.1 + 6 + 9.2 + 3.7 = 24 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Seneca Foods Corporationthis pageSENEB | 59.4/100Thin evidence · provisional46% evidence | 22.8/35 Revenue 5.1% · PAT 100% · OPM change 5.4 pp 53% evidence | 10.9/25 ROCE 2.3% · OPM 6% 57% evidence | 15.7/20 P/E 9.1× · PEG 0.28 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y 79.3%7 of 9 weeks ahead 0% evidence | |
| Exact sum: 22.8 + 10.9 + 15.7 + 10 = 59.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Herbalife Ltd.HLF | 55.7/100Thin evidence · provisional50% evidence | ASLEEP | 17.4/35 Revenue 3.7% · PAT -15% · OPM change 0.4 pp 53% evidence | 14.9/25 ROCE 8.1% · OPM 10.5% 57% evidence | 11.5/20 P/E 6.5× · PEG — 15% evidence | 11.9/20 RS sector 1.1% · RS bench -13.4% · 1Y 41.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.4 + 14.9 + 11.5 + 11.9 = 55.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Westrock Coffee CompanyWEST | 52.8/100Thin evidence · provisional48% evidence | ASLEEP | 21.6/35 Revenue 47.3% · PAT — · OPM change 7.1 pp 40% evidence | 7.3/25 ROCE 0.4% · OPM 1% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 13.9/20 RS sector 43.1% · RS bench 25.4% · 1Y 73.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 7.3 + 10 + 13.9 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Once Upon A Farm, PBCOFRM | 45.2/100Thin evidence · provisional28% evidence | ASLEEP | 19.6/35 Revenue 48.6% · PAT — · OPM change -4 pp 40% evidence | 5.6/25 ROCE -15.8% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence |
| Exact sum: 19.6 + 5.6 + 10 + 10 = 45.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30The Magnum Ice Cream Company N.V.MICC | 44.8/100Thin evidence · provisional18% evidence | FADING | 16.7/35 Revenue — · PAT — · OPM change — 9% evidence | 9.4/25 ROCE 0.4% · OPM — 46% evidence | 8.7/20 P/E 28.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —11 of 12 weeks ahead 0% evidence |
| Exact sum: 16.7 + 9.4 + 8.7 + 10 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Seneca Foods Corporation's stock price today?
Seneca Foods Corporation trades at $187, +79.3% over the past year. The company is valued at $1.0 B. The stock sits at 80% of its 52-week range of $102–$209. Against the S&P 500 it has been ahead on a trailing-13-week view for 6 weeks. — as of 28 September 2026.
What were Seneca Foods Corporation's latest quarterly results?
Seneca Foods Corporation reported revenue of $0.4 B and net profit of $0.0 B for the Mar 26 quarter. Earnings per share were $3.70. The operating margin was 5.1%, 5.1 pp higher than a year earlier. — as of 28 September 2026.
What is Seneca Foods Corporation's revenue?
Seneca Foods Corporation reported revenue of $0.4 B in the Mar 26 quarter, +11.4% year on year. For the full FY26 fiscal year, revenue was $1.7 B (+5.1%). Over the last 4 years revenue compounded at 4.5% a year. — as of 28 September 2026.
What is Seneca Foods Corporation's profit?
Seneca Foods Corporation earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY26 profit was $0.1 B. The operating margin ran 5.1% in the latest quarter. — as of 28 September 2026.
What is Seneca Foods Corporation's market cap?
Seneca Foods Corporation's market capitalisation is $1.0 B at a stock price of $187. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 28 September 2026.
What is Seneca Foods Corporation's P/E ratio?
Seneca Foods Corporation trades at a P/E of 10.4×, at the 40th percentile of its own 1-year range, against a long-run median of 11.1×. This is a comparison with the stock's own history, not a value call — as of 28 September 2026.
Does Seneca Foods Corporation pay a dividend?
No — Seneca Foods Corporation has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 28 September 2026.
Is Seneca Foods Corporation overvalued?
On its own history, Seneca Foods Corporation looks mid-range: its P/E of 10.4× sits at the 40th percentile of its 1-year range (long-run median 11.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 28 September 2026.
How is Seneca Foods Corporation performing?
Seneca Foods Corporation's latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 28 September 2026.
What stage is Seneca Foods Corporation in?
Improving — profit growth bottomed 3 quarters ago at −40.0% and has held its recovery at +266.7%, ROCE holding at 8.7%. The read comes from the last 12 quarters of growth (revenue growth +5.1% latest, profit growth +266.7% latest, eps growth +182.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 28 September 2026.
Is Seneca Foods Corporation beating the market?
On recent form, yes — Seneca Foods Corporation has been ahead of the S&P 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.2 years the stock moved +85% against the S&P 500's +24% — ahead of the index over the full window. — as of 28 September 2026.
Will Seneca Foods Corporation's stock price go up?
This page publishes no price forecast for Seneca Foods Corporation. What it measures instead: the stock price is $187. Its P/E of 10.4× sits at the 40th percentile of its own 1-year range. Direction is not something this site claims to know. — as of 28 September 2026.
Is the market betting against Seneca Foods Corporation?
No — short interest is 0.0% of Seneca Foods Corporation's tradable float, about 7.7 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 28 September 2026.
Does Seneca Foods Corporation have too much debt?
It is moderate — Seneca Foods Corporation's debt-to-equity is 0.31. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 28 September 2026.
What is Seneca Foods Corporation's capex?
Seneca Foods Corporation spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 28 September 2026.
What is Seneca Foods Corporation's cash flow?
Seneca Foods Corporation generated $0.2 B of operating cash flow in FY26 and $0.2 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 28 September 2026.
Is Seneca Foods Corporation's profit real cash?
Yes — over the last 3 fiscal years, 229% of Seneca Foods Corporation's reported profit arrived as operating cash. Though the latest year ran at 200% — the trend is the thing to watch. In FY26, operating cash was $0.2 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 28 September 2026.
How financially safe is Seneca Foods Corporation?
On the balance sheet, the Z-score reads 4.38 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 28 September 2026.
Where is Seneca Foods Corporation in its business cycle?
Seneca Foods Corporation's FY26 operating margin was 9.0%, against a 5-year band of 1.3%–9.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 5.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 28 September 2026.
What could break the Seneca Foods Corporation story?
The sharpest disagreement: annual EPS moved +181.2% against a +79.3% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 28 September 2026.
Is Seneca Foods Corporation a stock worth studying right now?
This is not investment advice. The machine read: Seneca Foods Corporation's earnings have outrun its stock. EPS grew +181.2% in a year against a +79.3% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 28 September 2026.
Not SEBI Registered !! Not Investment advice !!